Valneva UK

Supporting excellence in travel health

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Our vision is to contribute to a world in which no one dies or suffers from a vaccine-preventable disease.
Valneva UK Limited is focused on the marketing and distribution in the United Kingdom of Valneva’s vaccines IXIARO® Japanese encephalitis vaccine (inactivated adsorbed) and DUKORAL® cholera vaccine (inactivated, oral).
This website is intended for UK based healthcare professionals.

Together in partnership

It is our ambition to be recognised as a preferred business development partner supporting UK healthcare providers in offering convenient and clinically robust travel health services to patients, consumers and businesses.

Our Objectives


Increase awareness of travel-related health risks and encourage travellers to seek professional advice before travelling.


Improve accessibility and convenience for travellers seeking advice by supporting the development and expansion of clinics offering comprehensive, high quality and clinically robust travel health services.


Support healthcare professionals to effectively communicate the benefits of travel health advice to increase the number of travellers protected.

How we will achieve this

  • Unique ProductsSupplying a complimentary portfolio of vaccines and added value travel health products to benefit travellers and clinics.
  • Developing PartnershipsBuilding mutually beneficial partnerships with healthcare providers to help them realise opportunities within the travel health market and grow their business.
  • HCP EducationSupporting healthcare professional education and mentoring to enhance travel health service consultations.
  • Clinic SupportDeveloping and providing a range of clinic support materials and tools designed to support partner clinic services.

Our Products

Disease Awareness


Medical enquiries
T +44 1506 446608

Medical Requests COVID-19 Vaccine Candidate
Valneva is developing VLA2001, currently the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe. For medical questions related to Valneva’s COVID-19 vaccine candidate please call +43 1 20620 1444 or send an email to

Adverse events
Adverse events should be reported. Reporting forms and information can be found at

Adverse events should also be reported to Valneva via email:

2022 - Update your browser...